IL125628A0 - Benzo[c] quinolizine derivatives their preparation and use as 5alpha-reductase inhibitors - Google Patents

Benzo[c] quinolizine derivatives their preparation and use as 5alpha-reductase inhibitors

Info

Publication number
IL125628A0
IL125628A0 IL12562897A IL12562897A IL125628A0 IL 125628 A0 IL125628 A0 IL 125628A0 IL 12562897 A IL12562897 A IL 12562897A IL 12562897 A IL12562897 A IL 12562897A IL 125628 A0 IL125628 A0 IL 125628A0
Authority
IL
Israel
Prior art keywords
benzo
preparation
5alpha
reductase inhibitors
quinolizine derivatives
Prior art date
Application number
IL12562897A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL125628A0 publication Critical patent/IL125628A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL12562897A 1996-02-09 1997-02-07 Benzo[c] quinolizine derivatives their preparation and use as 5alpha-reductase inhibitors IL125628A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96FI000019A IT1286545B1 (it) 1996-02-09 1996-02-09 Derivati benzo(c) chinolizinici,loro preparazione ed uso come inibitori delle 5-alfa-riduttasi
PCT/EP1997/000552 WO1997029107A1 (en) 1996-02-09 1997-02-07 BENZO[C]QUINOLIZINE DERIVATIVES, THEIR PREPARATION AND USE AS 5α-REDUCTASES INHIBITORS

Publications (1)

Publication Number Publication Date
IL125628A0 true IL125628A0 (en) 1999-04-11

Family

ID=11351478

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12562897A IL125628A0 (en) 1996-02-09 1997-02-07 Benzo[c] quinolizine derivatives their preparation and use as 5alpha-reductase inhibitors
IL125628A IL125628A (en) 1996-02-09 1998-08-03 Pharmaceutical preparations containing benzo [C] quinolizines steroid inhibitors 5 - alpha reductase, some such new compounds and their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL125628A IL125628A (en) 1996-02-09 1998-08-03 Pharmaceutical preparations containing benzo [C] quinolizines steroid inhibitors 5 - alpha reductase, some such new compounds and their preparation

Country Status (26)

Country Link
US (3) US6303622B1 (es)
EP (1) EP0880520B1 (es)
JP (1) JP2000504680A (es)
KR (1) KR100480448B1 (es)
CN (1) CN1116296C (es)
AT (1) ATE237614T1 (es)
AU (1) AU711886C (es)
BG (1) BG64596B1 (es)
CZ (1) CZ298061B6 (es)
DE (1) DE69720966T2 (es)
DK (1) DK0880520T3 (es)
EA (1) EA000975B1 (es)
EE (1) EE04058B1 (es)
ES (1) ES2192263T3 (es)
HK (1) HK1018783A1 (es)
HU (1) HUP9900509A3 (es)
IL (2) IL125628A0 (es)
IT (1) IT1286545B1 (es)
MX (1) MX9806229A (es)
NO (2) NO320155B1 (es)
NZ (1) NZ331256A (es)
PL (1) PL187618B1 (es)
PT (1) PT880520E (es)
SK (1) SK283299B6 (es)
UA (1) UA67724C2 (es)
WO (1) WO1997029107A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI970193A1 (it) * 1997-08-01 1999-02-01 Applied Research Systems Uso di derivati benzo(c) chinolizinici come regolatori della crescita delle piante e composizioni ad uso agricolo che contengono tali
EP0926148A1 (en) * 1997-12-23 1999-06-30 Applied Research Systems Ars Holding N.V. Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors
WO2000008019A1 (en) * 1998-08-03 2000-02-17 Applied Research Systems Ars Holding N.V. Process for the synthesis of (1h)-benzo[c]quinolizin-3-ones derivatives
AU2006244072B2 (en) 2005-05-10 2012-09-20 Intermune, Inc. Pyridone derivatives for modulating stress-activated protein kinase system
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
US20060293345A1 (en) * 2005-05-20 2006-12-28 Christoph Steeneck Heterobicyclic metalloprotease inhibitors
US8304413B2 (en) 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
EP3126362B1 (en) 2014-04-02 2022-01-12 Intermune, Inc. Anti-fibrotic pyridinones
CN105001216B (zh) * 2015-07-08 2017-03-01 中国科学院兰州化学物理研究所 一种喹嗪酮的制备方法
CN107089980B (zh) * 2017-05-11 2019-08-30 合肥工业大学 一种手性苯并[a]喹嗪-2-酮类化合物及其不对称催化合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1534278A (fr) * 1966-08-15 1968-07-26 Bristol Myers Co Procédé de fabrication de 1, 4-dihydroquinoléine-n-carboxylates d'alcoyle
US3455929A (en) * 1966-08-15 1969-07-15 Bristol Myers Co Esters of 1,4-dihydroquinoline-n-carboxylic acids and thione acids
US3625877A (en) * 1968-01-08 1971-12-07 Eastman Kodak Co High-modulus polycarbonate compositions
SU1027166A1 (ru) * 1981-09-11 1983-07-07 Киевский Ордена Ленина Государственный Университет Им.Т.Г.Шевченко Способ получени 1,2-полиметиленкетоцианоазагетероциклов
IE57014B1 (en) 1983-03-25 1992-03-11 Wyeth John & Brother Ltd Benzoquinolizines

Also Published As

Publication number Publication date
US6555549B2 (en) 2003-04-29
ITFI960019A0 (es) 1996-02-09
BG64596B1 (bg) 2005-08-31
AU711886B2 (en) 1999-10-21
NO20045132L (no) 1998-07-24
DE69720966D1 (de) 2003-05-22
NZ331256A (en) 1999-06-29
EP0880520B1 (en) 2003-04-16
US6552034B2 (en) 2003-04-22
AU711886C (en) 2002-10-17
ATE237614T1 (de) 2003-05-15
EP0880520A1 (en) 1998-12-02
PT880520E (pt) 2003-07-31
UA67724C2 (en) 2004-07-15
SK104498A3 (en) 1998-12-02
AU1767297A (en) 1997-08-28
DK0880520T3 (da) 2003-08-11
IT1286545B1 (it) 1998-07-15
WO1997029107A1 (en) 1997-08-14
EA199800701A1 (ru) 1999-02-25
CZ228998A3 (cs) 1998-10-14
PL187618B1 (pl) 2004-08-31
EA000975B1 (ru) 2000-08-28
US6303622B1 (en) 2001-10-16
BG102661A (en) 1999-04-30
KR100480448B1 (ko) 2005-08-31
CZ298061B6 (cs) 2007-06-06
ITFI960019A1 (it) 1997-08-09
HUP9900509A2 (hu) 1999-06-28
KR19990082126A (ko) 1999-11-15
MX9806229A (es) 1998-11-30
US20010047098A1 (en) 2001-11-29
NO983444D0 (no) 1998-07-24
ES2192263T3 (es) 2003-10-01
IL125628A (en) 2006-10-31
EE9800233A (et) 1998-12-15
SK283299B6 (sk) 2003-05-02
PL328123A1 (en) 1999-01-18
JP2000504680A (ja) 2000-04-18
NO983444L (no) 1998-07-24
HK1018783A1 (en) 2000-01-07
CN1210536A (zh) 1999-03-10
NO320155B1 (no) 2005-11-07
DE69720966T2 (de) 2004-05-19
EE04058B1 (et) 2003-06-16
US20010044542A1 (en) 2001-11-22
CN1116296C (zh) 2003-07-30
HUP9900509A3 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
ES2166270A1 (es) Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona.
BG66087B1 (bg) Хинолинонови производни като тирозин киназни инхибитори
MY132642A (en) Naphthyridine derivatives
GR3036253T3 (en) Cyclopropyl alkanoic acid derivatives
GB9914486D0 (en) Medicaments
HUP0100156A2 (hu) Foszfolipáz-A2 inhibitor hatású indolszármazékok és alkalmazásuk gyógyászati készítmények előállítására
BG103195A (en) Substituted indazole derivatives and their application as inhibitors of phosphodiesterase (pde) type iv and of the production of a tumournecrotic factor (tnf)
AU5699399A (en) Pyridyl-bridgehead derivatives and their analogues, pharmaceutical compositions and their use as inhibitors of nicotinic cholinergic receptors
FI102475B1 (fi) Menetelmä farmaseuttisesti aktiivisten oktahydro- ja heksahydrobentso[f]kinolinonijohdannaisten valmistamiseksi
IL125628A0 (en) Benzo[c] quinolizine derivatives their preparation and use as 5alpha-reductase inhibitors
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
HUP0202988A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
HK1053109A1 (en) Substituted homopiperidinyl benzimidazole compounds, pharmaceutical compositions comprising the same, methods for preparing them and the use for the preparation of a medicament of them
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
ATE241624T1 (de) Benzo(f)naphthyridinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammenstzungen
AP9801235A0 (en) Erythromycin derivatives.
DE69927997D1 (de) Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
CA2245758A1 (en) Benzo[c]quinolizine derivatives, their preparation and use as 5.alpha.-reductases inhibitors
WO2000037465A3 (en) Novel derivatives of swainsonine, processes for their preparation, and their use as therapeutic agents
DE69824410D1 (en) Antithrombosemittel
AU1434201A (en) Antithrombotic agents

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed